Market

The deal, announced by the US Justice Department, was the latest to result from an industry-wide probe of drugmakers' financial…

LANXESS optimises production capacities of Rely+On Virkon for increased delivery capability

China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates in 2018-19 at USD 2,405.42 million

The company had posted a net profit of Rs 510.7 crore for the corresponding period of the previous fiscal, Cadila Healthcare said…

Growth across key business drove overall revenue growth of 9 per cent on a year on year basis with adjusted EBITDA at 18.5 per…

The launch strengthens GSK’s pain relief portfolio in India making it one of the formidable players in the non-prescription space.…

The international technology group managed to increase its sales by 5.1 per cent to around EUR 2.2 billion. The operating result…

The company will develop and launch a portfolio of vitamins and nutritional supplements in gummy format, without the use of…

Triferic is an innovative anaemia therapy for the patients who are undergoing haemodialysis and offers a unique treatment option

Under the deal, Pfizer will get $75 million upfront and will be eligible for $635 million in potential milestone payments